NCIt definition : The acetate salt of a synthetic cyclic octapeptide analogue of somatostatin. Lanreotide
binds to somatostatin receptors (SSTR), specifically SSTR-2 and also to SSTR-5 with
a lesser affinity. However, compare with octreotide, this agent is less potent in
inhibiting the release of growth hormone from the pituitary gland. Furthermore, lanreotide
has an acute effect on decreasing circulating total and free insulin-like growth factor
1 (IGF-I). This agent is usually given as a prolonged-release microparticle or Autogel
formulation for the treatment of acromegaly and to relieve the symptoms of neuroendocrine
tumors.;
UNII : IEU56G3J9C;
CAS number : 127984-74-1; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 127984-74-1
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;